Inventor · disambiguated record
Lyne Gagnon
Also filed as: GAGNON LYNE
28 granted patents·13 pending applications·127 citations·filing 1995–2023
95Inventor score
Files withPROMETIC PHARMA SMT LTD9LIMINAL BIOSCIENCES LTD6PROMETIC BIOSCIENCES INC6GAGNON LYNE5PENNEY CHRISTOPHER4
Top patents by PatentIndex Score
41 records- 0187US9439882B2Compounds and compositions for the treatment of cancerPROMETIC BIOSCIENCES INC·Filed 2015·Granted Sep 13, 2016·3 cites·15 claims
- 0284US8946190B2Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancerGAGNON LYNE·Filed 2008·Granted Feb 3, 2015·4 cites·14 claims
- 0382US10869849B2Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regenerationLIMINAL BIOSCIENCES LTD·Filed 2019·Granted Dec 22, 2020·1 cites·15 claims
- 0482US9938221B2Substituted aromatic compounds and pharmaceutical uses thereofPROMETIC BIOSCIENCES INC·Filed 2014·Granted Apr 10, 2018·4 cites·10 claims
- 0582US9884802B2Substituted aromatic compounds for the treatment pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosisPROMETIC BIOSCIENCES INC·Filed 2014·Granted Feb 6, 2018·6 cites·29 claims
- 0682US5994361ASubstituted purinyl derivatives with immunomodulating activityBIOCHEM PHARMA·Filed 1995·Granted Nov 30, 1999·69 cites·23 claims
- 0781US10023518B2Substituted aromatic compounds and related method for the treatment of fibrosisPROMETIC BIOSCIENCES INC·Filed 2014·Granted Jul 17, 2018·4 cites·12 claims
- 0880US8927765B2Substituted aromatic compounds and pharmaceutical uses thereofZACHARIE BOULOS·Filed 2011·Granted Jan 6, 2015·4 cites·23 claims
- 0980US7745488B2Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factorsPROMETIC BIOSCIENCES INC·Filed 2002·Granted Jun 29, 2010·14 cites·18 claims
- 1079US10550066B2Substituted aromatic compounds and related method for the treatment of fibrosisPROMETIC PHARMA SMT LTD·Filed 2018·Granted Feb 4, 2020·2 cites·8 claims
- 1178US10391073B2Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regenerationPROMETIC PHARMA SMT LTD·Filed 2015·Granted Aug 27, 2019·1 cites·19 claims
- 1275US8637574B2Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereofZACHARIE BOULOS·Filed 2010·Granted Jan 28, 2014·3 cites·25 claims
- 1373US9114118B2Compounds and compositions for the treatment of cancerGAGNON LYNE·Filed 2011·Granted Aug 25, 2015·1 cites·19 claims
- 1472US10450258B2Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosisPROMETIC PHARMA SMT LTD·Filed 2017·Granted Oct 22, 2019·1 cites·20 claims
- 1572US2023346893A1Methods and Compositions for Preventing or Minimizing Epithelial-Mesenchymal TransitionINNOVON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1671US8487001B2Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factorsGAGNON LYNE·Filed 2010·Granted Jul 16, 2013·2 cites·20 claims
- 1770US11267779B2Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosisPROMETIC PHARMA SMT LTD·Filed 2019·Granted Mar 8, 2022·0 cites·19 claims
- 1870US8258295B2Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivativesZACHARIE BOULOS·Filed 2008·Granted Sep 4, 2012·1 cites·19 claims
- 1969US11524930B2Substituted aromatic compounds and related method for the treatment of fibrosisLIMINAL BIOSCIENCES LTD·Filed 2020·Granted Dec 13, 2022·0 cites·19 claims
- 2068US10815183B2Substituted aromatic compounds and pharmaceutical uses thereofPROMETIC PHARMA SMT LTD·Filed 2018·Granted Oct 27, 2020·0 cites·20 claims
- 2167US9475750B2Phenylketone carboxylate compounds and pharmaceutical uses thereofZACHARIE BOULOS·Filed 2011·Granted Oct 25, 2016·1 cites·24 claims
- 2267US2021002202A1Substituted Aromatic Compounds and Pharmaceutical Uses ThereofPROMETIC PHARMA SMT LTD·Filed 2020·Application pending·0 cites
- 2366US8071580B2Medium-chain length fatty alcohols as stimulators of hematopoiesisPENNEY CHRISTOPHER·Filed 2005·Granted Dec 6, 2011·1 cites·30 claims
- 2465US9682054B2Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesisPENNEY CHRISTOPHER·Filed 2004·Granted Jun 20, 2017·1 cites·36 claims
- 2564US2021085626A1Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regenerationLIMINAL BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 2662US7683061B2Triazine dimers for the treatment of autoimmune diseasesPROMETIC BIOSCIENCES INC·Filed 2004·Granted Mar 23, 2010·3 cites·24 claims
- 2758US11185521B2Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosisLIMINAL BIOSCIENCES INC·Filed 2020·Granted Nov 30, 2021·0 cites·20 claims
- 2857US2021128694A1Methods and compositions for preventing or minimizing epithelial-mesenchymal transitionPROMETIC PHARMA SMT LTD·Filed 2017·Application pending·0 cites
- 2957US2024043372A1Substituted aromatic compounds and pharmaceutical compositions thereofPHARMACEUTIQUE INGENEW INC·Filed 2021·Application pending·0 cites
- 3055US9532962B2Medium-chain length fatty acids and glycerides as nephroprotection agentsPICHETTE VINCENT·Filed 2008·Granted Jan 3, 2017·1 cites·13 claims
- 3153US2022016060A1Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alström syndromeLIMINAL BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
- 3253US2009075867A1Triazine compounds and compositions thereof for the treatment of cancersGAGNON LYNE·Filed 2006·Application pending·0 cites
- 3350US2023107538A1Cycloalkyl-containing carboxylic acids and uses thereofLIMINAL BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 3447US2008090848A1Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or GlyceridesPENNEY CHRISTOPHER·Filed 2005·Application pending·0 cites
- 3544US11826404B2Plasminogen treatment of conditions associated with PAI-1 overexpressionPROMETIC BIOTHERAPEUTICS INC·Filed 2018·Granted Nov 28, 2023·0 cites·20 claims
- 3642US2018228750A1Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosisPROMETIC PHARMA SMT LTD·Filed 2015·Application pending·0 cites
- 3741US10925846B2Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosisLIMINAL BIOSCIENCES LTD·Filed 2015·Granted Feb 23, 2021·0 cites·17 claims
- 3840US2005101632A1Method for the treatment of inflammationFiled 2001·Application pending·0 cites
- 3936US10105331B2Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetesPROMETIC PHARMA SMT LTD·Filed 2015·Granted Oct 23, 2018·0 cites·30 claims
- 4033US2009068169A12,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their usePENNEY CHRISTOPHER·Filed 2005·Application pending·0 cites
- 4132US2013225683A1Compounds and Pharmaceutical Compositions for Uses in DiabetesGAGNON LYNE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lyne Gagnon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →